Athena Capital (South Africa) logo

Athena Capital (South Africa)

Africa, NA - South Africa, South Africa, Cape Town

Description

Athena Capital is an established private equity firm specializing in investments in middle market acquisitions.

Investor Profile

Athena Capital (South Africa) has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (100%)

Country Focus

  • Germany (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Life Science
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Athena Capital (South Africa) frequently co-invest with?

BVCF
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Platinum Asset Management
Oceania, New South Wales, Australia, Sydney
Co-Investments: 1
Redmile Group
North America, California, United States, San Francisco
Co-Investments: 1
Jebsen Capital
Asia, Hong Kong Island, Hong Kong, Causeway Bay
Co-Investments: 1
MF
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Invus
North America, New York, United States, New York
Co-Investments: 1
Fidelity
North America, Massachusetts, United States, Boston
Co-Investments: 1

What are some of recent deals done by Athena Capital (South Africa)?

BioNTech

Mainz, Rheinland-Pfalz, Germany

BioNTech is a biopharmaceutical company that develops cancer therapeutics for infectious diseases.

BiopharmaBiotechnologyLife SciencePharmaceutical
Series BJul 9, 2019
Amount Raised: $325,000,000